By receiving your generous support CTRT can run a comprehensive program of clinical trials for patients with melanoma and renal cancer. This allows our patients access to the most modern treatments whilst also improving our understanding of the diseases we treat and identification of opportunities to improve outcomes. Donations to CTRT that stipulate use for the melanoma and renal teams will only be used to support research in the areas the donor desires.
The research team is led by Dr Paul Nathan (melanoma and renal cancer), Dr Heather Shaw (melanoma) and Dr Anand Sharma (renal cancer). Our research nurses Ange Smith, Simona Linwood, Kelly Chan; study coordinators Rowena Sahabandu, Smruti Gorsia, Jo Pascoe; clinical trials practitioner Christiana Groutides and Trials assistant Simran Sumal run all aspects of clinical trials from patient care to data management. 80% of their salaries are covered by charitable funds and commercial trial income, only one salary is received from the national cancer research network. Our patients, therefore, have access to the most innovative treatments because of the generosity of contributors to CTRT.
Our renal cancer clinical trial portfolio continues to grow. Patients now have the opportunity to access clinical trials in the adjuvant (following surgery) and advanced disease settings. Many of our studies are attempting to identify improved ways to stimulate an effective immune response to the cancer in an attempt to gain long term control of the disease.